SS Innovations Reports Record Q2 Revenue as SSi Mantra Robotic Surgery Platform Gains Global Traction

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has reported record second-quarter revenue of $13.9 million, a 39.4% increase from $10.0 million in the same period last year. The company's first-half revenue reached $25.0 million, up 65.6% from $15.1 million in the prior year, signaling robust demand for its SSi Mantra surgical robotic system.

The company's growth is largely driven by the installation of its SSi Mantra systems, which rose 30.4% during the quarter to 30 systems. This brings the total installed base to 224 systems across 12 countries, with 12,272 cumulative surgeries performed to date. The expanding installed base underscores the platform's increasing adoption and the company's footprint in the global surgical robotics market.

SS Innovations has also made significant strides in telesurgery, extending the clinical profile of SSi Mantra and demonstrating its capabilities beyond traditional surgical settings. While system installations remain the primary commercial growth driver, these technological achievements could open new opportunities and applications for the platform.

Looking ahead, regulatory milestones in the U.S. and Europe are expected to serve as important catalysts for the company. SS Innovations is targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. Achieving these milestones would likely expand market access and could accelerate adoption of the SSi Mantra system in key developed markets.

The company's gross profit for the second quarter increased 20.0% to $7.1 million, though gross margin declined to 50.9% from 59.1% in the year-earlier quarter. For the first half, gross profit jumped 77.5% to $12.4 million, with an improved margin compared to the prior-year period. These financial results highlight the company's ability to scale while managing costs effectively.

The robust revenue growth and expanding installed base position SS Innovations as a notable player in the surgical robotics industry. As the company approaches regulatory milestones, its impact on the healthcare sector could be significant, offering advanced robotic surgery options to a broader range of patients and healthcare providers. For more information on SS Innovations, visit their newsroom at https://ibn.fm/SSII.